S
Si-Xue Cheng
Researcher at Wuhan University
Publications - 238
Citations - 12634
Si-Xue Cheng is an academic researcher from Wuhan University. The author has contributed to research in topics: Drug carrier & Micelle. The author has an hindex of 54, co-authored 236 publications receiving 10754 citations. Previous affiliations of Si-Xue Cheng include Sichuan University & University of South China.
Papers
More filters
Journal ArticleDOI
Macroporous poly(N-isopropylacrylamide) hydrogels with fast response rates and improved protein release properties.
TL;DR: The study on the drug release properties shows the macroporous hydrogels exhibit modulated release in response to temperature, and the PNIPA gels thus prepared have remarkably larger swelling ratios below their lower critical solution temperature (LCST), and exhibit much faster response rates as the temperature is raised above their LCST.
Journal ArticleDOI
Alginate modified nanostructured calcium carbonate with enhanced delivery efficiency for gene and drug delivery
TL;DR: The study on in vitro cell inhibition effects showed that the cell viability decreased with increasing DOX amount loaded in alginate/CaCO(3)/DNA/DOX nanoparticles, and the nanoparticles prepared in this study have promising applications in gene and drug delivery.
Journal ArticleDOI
Highly Integrated Nano-Platform for Breaking the Barrier between Chemotherapy and Immunotherapy
Di-Wei Zheng,Jia-Li Chen,Jia-Li Chen,Jing-Yi Zhu,Lei Rong,Bin Li,Qi Lei,Jin-Xuan Fan,Mei-Zhen Zou,Cao Li,Si-Xue Cheng,Zushun Xu,Xian-Zheng Zhang +12 more
TL;DR: Compared with the traditional tumor chemotherapy, the integrated theranostic nanoplatform developed not only improved the tumor specific cytotoxicity but also stimulated antitumor immune responses during the treatment.
Journal ArticleDOI
Tumor‐Microenvironment‐Triggered Ion Exchange of a Metal–Organic Framework Hybrid for Multimodal Imaging and Synergistic Therapy of Tumors
TL;DR: In vivo data show that the pro‐NTA activation strategy could selectively brighten solid tumors and detect invisible lymph node metastases with high specificity, and guarantee a more efficient therapeutic performance compared to monotherapy.
Journal ArticleDOI
Smart and hyper-fast responsive polyprodrug nanoplatform for targeted cancer therapy
Xiao-Ding Xu,Xiao-Ding Xu,Yin-Jia Cheng,Jun Wu,Hong Cheng,Si-Xue Cheng,Ren-Xi Zhuo,Xian-Zheng Zhang +7 more
TL;DR: A new smart and hype-responsive polyprodrug platform with five key elements, which has the following unique characteristics: high and constant drug loading, excellent tumor-targeting performance, hyper-fast redox-responsive drug release, long blood circulation and significant inhibition of tumor growth without side effects.